Apremilast PSK

Immunosuppression

Apremilast PSK

Registration certificate:

INN:

Apremilast

Release form:

Film-coated tablets

Therapeutic Area:

Immunosuppression

Pharmacotherapeutic Group:

Immunosuppression, Selective immunosuppressants

Conditions for dispensing:

On prescription

Packaging:

Indications for Use: The drug Apremilast PSK is used in adults over the age of 18:

for the treatment of active psoriatic arthritis (PsA);
for the treatment of plaque psoriasis of moderate to severe severity in patients who require phototherapy or systemic therapy;
for the treatment of patients with oral ulcers caused by Behcet's disease (BB), who are indicated for systemic therapy.

This product is included in the Essential Drug List (EDL).

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical instruction for Apremilast PSK, please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx